Postmenopausal state | Breast Carcinoma | Aromatase Inhibitors Planned
Item
post menopausal breast cancer patients with planned treatment of aromatase inhibitors.
boolean
C0232970 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
C0593802 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Age
Item
18 years or older
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
bmi >30 or <18
boolean
C1305855 (UMLS CUI [1])
Osteoporosis
Item
osteoporosis as defined by protocol.
boolean
C0029456 (UMLS CUI [1])
Diphosphonates
Item
subjects currently on bisphosphonate therapy.
boolean
C0012544 (UMLS CUI [1])
Hyperparathyroidism, Primary | Hyperparathyroidism, Secondary
Item
history of primary or secondary hyperparathyroidism
boolean
C0221002 (UMLS CUI [1])
C0020503 (UMLS CUI [2])
Hypothyroidism | Hyperthyroidism
Item
history of hypo-or hyperthyroidism
boolean
C0020676 (UMLS CUI [1])
C0020550 (UMLS CUI [2])
Decreased vitamin D
Item
history of vitamin d levels below lln
boolean
C0919766 (UMLS CUI [1])
Creatinine clearance Less Than Estimated Glomerular Filtration Rate
Item
history of creatinine clearance below the egfr
boolean
C0812399 (UMLS CUI [1,1])
C0439092 (UMLS CUI [1,2])
C3811844 (UMLS CUI [1,3])
Increased liver function tests | LDH elevated | Aspartate aminotransferase increased | Alanine aminotransferase increased | Serum alkaline phosphatase raised | Serum bilirubin increased
Item
history ofliver function tests above 1.5 times uln including ldh, sgot, sgpt, alkaline phosphatase, and bilirubin
boolean
C0877359 (UMLS CUI [1])
C0151754 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C1314665 (UMLS CUI [5])
C0859062 (UMLS CUI [6])
Liver Cirrhosis
Item
history of documented cirrhosis of the liver
boolean
C0023890 (UMLS CUI [1])
Heparin use chronic
Item
history of chronic heparin use
boolean
C0239945 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Glucocorticoid therapy chronic
Item
history of chronic glucocorticoid therapy
boolean
C0744425 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])